Events
GlaxoSmithKline has decided not to make a play for Pfizer’s consumer health business. The decision came one day after another potential suitor walked away from a potential deal.
Rheos Medicines, backed by Third Rock Ventures, launched with a $60 million Series A financing. The company will focus on immunometabolism to treat disease.
The second time proved to be the charm for the U.S. House of Representatives to pass right-to-try legislation that would provide terminally ill patients access to experimental drugs without the approval of the U.S. FDA.
Here’s a look at eight biopharma companies with upcoming catalysts.
Today, on this 11th World Rare Disease Day, life science companies, organization and activists have come together to raise awareness about these diseases and the needs of therapies for patients.
Here is a look at the life science companies viewed as the most innovative in the world.
Recently, Dr. Wang discussed China life science with partneringNEWS, a publication of EBD Group. ChinaBio and EBD will hold the tenth iteration of the ChinaBio Partnering Forum in Suzhou, China on April 25-26, 2018.
The 28-year-old CEO of Ascendance Biomedical removed his trousers and injected himself at the BDYHAX conference in Texas.
During an international conference in Davos, Switzerland, President Donald Trump sat down with the leaders of several European life science companies to encourage more investment in the United States.
TxCell today reports its fourth quarter 2017 financials and provides an update on its financing.
PRESS RELEASES